Patents Assigned to Molecules of Man AB
  • Patent number: 7837996
    Abstract: The present invention relates to materials and methods for treatment of hepatitis C. More closely, the invention relates to human monoclonal antibodies against HCV E1 antigen, to a reagent comprising such antibodies, and to vaccine compositions comprising such antibodies. Furthermore, the invention relates to a method of treating or preventing HCV infection by administration of a vaccine composition comprising the monoclonal antibodies of the invention.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: November 23, 2010
    Assignee: Molecules of Man AB
    Inventors: Katarina Drakenberg, Mats A. A. Persson
  • Patent number: 7250166
    Abstract: The present invention relates to materials and methods for treatment of hepatitis C. More closely, the invention relates to human monoclonal antibodies against HCV E1 antigen, to a reagent comprising such antibodies, and to vaccine compositions comprising such antibodies. Futhermore, the invention relates to a method of treating or preventing HCV infection by administration of a vaccine composition comprising the monoclonal antibodies of the invention.
    Type: Grant
    Filed: January 14, 2002
    Date of Patent: July 31, 2007
    Assignee: Molecules of Man AB
    Inventors: Katarina Drakenberg, Mats A. A. Persson